Artenda Pharmaceuticals Private Limited
About Artenda Pharmaceuticals Private Limited
Data last updated:
Artenda Pharmaceuticals Private Limited was a private limited company based in Chennai, Tamil Nadu, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the retail trading segment of the trading and commerce sector. It was incorporated on 06 June 2013.
The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U33111TN2013PTC091517. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Rethinam Ganesan and Neelakandan Srinivasan.
Its last annual general meeting (AGM) was held on 29 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at No.2 Lakshmi Nagar 1st Floor Gerugambakkam, Chennai, Tamil Nadu, India – 600112.
As per the financials filed for FY 2017, the company reported a revenue of ₹19.71 Lakh, a growth of 118% compared to the previous year. For the same year it recorded a net profit of ₹22,836 (net margin 1.2%) and EBITDA of ₹38,077 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years.
Company details
Contact details
Artenda Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.2 Lakshmi Nagar 1st Floor Gerugambakkam, Chennai, Tamil Nadu, India – 600112
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Artenda Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Artenda Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Artenda Pharmaceuticals Private Limited, buy the company report.
Financials of Artenda Pharmaceuticals Private Limited
FY 2017 filings availableArtenda Pharmaceuticals Private Limited reported revenue of ₹19.71 Lakh (up 118% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 67% over three years, including 118% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹38,077 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹22,836 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.9% | ||
| Net Profit Margin | 1.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Artenda Pharmaceuticals Private Limited, buy the company report.
Board of directors of Artenda Pharmaceuticals Private Limited
Artenda Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rethinam Ganesan | Director | 03 May 2014 | 12 Years 6 Months | As last reported |
| Neelakandan Srinivasan | Director | 07 Sep 2018 | 8 Years 1 Months | As last reported |
| Venkataraman Krishnamoorthy Also directs: Liger Life Links (OPC) Private Limited | Director | 05 Apr 2018 | 8 Years 6 Months | As last reported |
Peer comparison
Artenda Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Niyogen Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2024) | -10.0% | Sultanganj Patna, Bihar, India | |||
| Astrakind Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2024) | 275.0% | Jaipur, Rajasthan, India | |||
| Ridus Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Artenda Pharmaceuticals Private Limitedthis company | ₹19.71 Lakh (FY 2017) | ₹22,836 | 1.2% | 118.0% | Chennai, Tamil Nadu, India | |
| Loenz Pharmaceuticals (OPC) Private Limited | ₹19.71 Lakh (FY 2021) | 302.0% | Saharsa, Bihar, India | |||
| Bedrock Pharmaceuticals Private Limited | ₹19.71 Lakh (FY 2025) | 26.0% | Rudrapur, Uttarakhand, India | |||
| Alrosa Pharmaceuticals Private Limited | ₹19.64 Lakh (FY 2025) | -26.0% | Ambala, Haryana, India |
To see the full peer comparison of Artenda Pharmaceuticals Private Limited, buy the company report.
Auditor
Artenda Pharmaceuticals Private Limited is audited by N SATHIYAMOORTHY & ASSOCIATES for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N SATHIYAMOORTHY & ASSOCIATES | FY 2015 | 008662S |
Shareholding
The shareholding of Artenda Pharmaceuticals Private Limited is on record for FY 2015, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2015 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Artenda Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Artenda Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Artenda Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Artenda Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Artenda Pharmaceuticals Private Limited, buy the company report.
Recent activity
Artenda Pharmaceuticals Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Ganesan Magesh ceased to be Director on 12 Dec 2019.
Frequently asked questions
Artenda Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Artenda Pharmaceuticals was a private limited company based in Chennai, Tamil Nadu, India. The company worked in retail trading, within the trading industry. It was incorporated on 06 June 2013 and is registered under CIN U33111TN2013PTC091517. The company has been struck off by the Registrar of Companies and is no longer operational.
Artenda Pharmaceuticals had 3 directors:
- Rethinam Ganesan - Director
- Neelakandan Srinivasan - Director
- Venkataraman Krishnamoorthy - Director
The CIN (Corporate Identification Number) of Artenda Pharmaceuticals is U33111TN2013PTC091517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Artenda Pharmaceuticals is at No.2 Lakshmi Nagar 1st Floor Gerugambakkam, Chennai, Tamil Nadu, India – 600112.
Artenda Pharmaceuticals was incorporated on 06 June 2013. It is registered with the Registrar of Companies, Chennai.
The latest financial statements of Artenda Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 29 September 2017. Year-wise statements from 2015 are in the company report.
No. Artenda Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Artenda Pharmaceuticals operated in the trading industry, in the retail trading segment. It worked in this industry before it was struck off.
The peers of Artenda Pharmaceuticals by revenue are Niyogen Pharmaceuticals Private Limited, Astrakind Pharmaceuticals Private Limited, Ridus Pharmaceuticals Private Limited, Loenz Pharmaceuticals (OPC) Private Limited, Bedrock Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ganesan Magesh ceased to be Director on 12 Dec 2019. Neelakandan Srinivasan was appointed as Director on 07 Sep 2018. Venkataraman Krishnamoorthy was appointed as Director on 05 Apr 2018. Artenda Pharmaceuticals has 5 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
